EP1176942A1 - Composition cosmetique renfermant un oligosaccharide cyclique et un parfum - Google Patents

Composition cosmetique renfermant un oligosaccharide cyclique et un parfum

Info

Publication number
EP1176942A1
EP1176942A1 EP00926513A EP00926513A EP1176942A1 EP 1176942 A1 EP1176942 A1 EP 1176942A1 EP 00926513 A EP00926513 A EP 00926513A EP 00926513 A EP00926513 A EP 00926513A EP 1176942 A1 EP1176942 A1 EP 1176942A1
Authority
EP
European Patent Office
Prior art keywords
fragrance
composition according
cyclic oligosaccharide
composition
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP00926513A
Other languages
German (de)
English (en)
Inventor
Peter James Malton
Lynette Anne Makins Holland
George Rizzi
Gabor Heltovics
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of EP1176942A1 publication Critical patent/EP1176942A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Definitions

  • the present invention relates to cosmetic compositions and in particular to long- lasting fragrance compositions.
  • compositions that they comprise a fragrance.
  • a fragrance can mask unpleasant odours or can improve consumer acceptance of a composition through delivering a pleasant smell.
  • the sole purpose of some compositions is the application of a pleasant odour to the skin, hair or other suitable substrate.
  • the fragrant effect of these compositions is transitory and the fragrance quickly becomes imperceptible.
  • the fragrance may be formulated in such a way as to include a higher proportion of fragrance materials with a low volatility. This means the fragrance persists for longer. However, using less volatile materials restricts the fragrance characters that can be achieved. It has also been suggested that it may be possible to utilise cyclic oligosaccharides, and in particular cyclodextrins.
  • JP-A-50/63126 discloses perfume and cyclodextrin complexes for use in bath preparations
  • JP-A-7/241333 discloses a long-lasting, room deodorising composition containing a fragrance and cyclodextrin.
  • compositions comprising greater than about 0.2%, by weight, fragrance and cyclic oligosaccharide having an average degree of substitution of at least about 1.6 provide an initial burst of fragrance and improved fragrance longevity.
  • the stability profile of the complexes formed between the fragrance and the cyclic oligosaccharide of the present invention is such that a perceptible amount of fragrance is released over a sufficiently long time to satisfy the consumers desire for long lasting fragrance.
  • cosmetic compositions comprising:
  • compositions of the present invention provide a long-lasting fragrance while at the same time having a 'burst' of fragrance on application.
  • the present invention relates to compositions comprising two essential elements, greater than 0.2% fragrance and cyclic oligosaccharide having an average degree of substitution of at least about 1.6. These two elements will be described in more detail below.
  • fragrance material comprises greater than about 0.2%, by weight, fragrance material.
  • fragrance material is used to indicate any odouriferous material. Any fragrance material suitable for use in cosmetic compositions may be used herein but the fragrance will most often be liquid at ambient temperatures. Preferably, the fragrance material will be present at a level of from about 0.25% to about 40%, more preferably from about 0.5% to about 30%, even more preferably from about 2.5% to about 25%, even more preferably still from about 8% to about 15%, by weight, of total composition.
  • chemicals are known for fragrance uses, including materials such as aldehydes, ketones and esters.
  • fragrances More commonly, naturally occurring plant and animal oils and exudates comprising complex mixtures of various chemical components are known for use as fragrances.
  • the fragrance materials useful herein include pro-fragrances such as acetal pro-fragrances, ketal pro- fragrances, ester pro-fragrances, hyrdolyzable inorganic-organic pro-fragrances and mixtures thereof.
  • the fragrance material may be released from the pro- fragrances in a number of ways.
  • the fragrance may be released as a result of simple hydrolysis, or by a shift in an equilibrium reaction, or by a pH- change, or by enzymatic release.
  • the fragrances herein can be relatively simple in their compositions, comprising a single chemical, or can comprise highly sophisticated complex mixtures of natural and synthetic chemical components, all chosen to provide any desired odour.
  • the fragrance materials of the present invention will have boiling points (BP) of about 500°C or lower, more preferably about 400°C or lower, even more preferably about 350°C or lower.
  • BP boiling points
  • the ClogP value of the fragrance materials useful herein is preferably greater than about 0.1 , more preferably greater than about 0.5, even more preferably greater than about 1.0, even more preferably still greater than about 1.2.
  • ClogP means the logarithm to the base 10 of the octanol/water partition coefficient. This can be readily calculated from a program called "CLOGP" which is available from Daylight Chemical Information Systems Inc., Irvine CA, USA. Octanol/water partition coefficients are described in more detail in US-A-5,578,563.
  • fragrances useful herein include, but are not limited to, animal fragrances such as musk oil, civet, castoreum, ambergris, plant fragrances such as nutmeg extract, cardomon extract, ginger extract, cinnamon extract, patchouli oil, geranium oil, orange oil, mandarin oil, orange flower extract, cedarwood, vetyver, lavandin, ylang extract, tuberose extract, sandalwood oil, bergamot oil, rosemary oil, spearmint oil, peppermint oil, lemon oil, lavender oil, citronella oil, chamomille oil, clove oil, sage oil, neroli oil, labdanum oil, eucalyptus oil, verbena oil, mimosa extract, narcissus extract, carrot seed extract, jasmine extract, olibanum extract
  • animal fragrances such as musk oil, civet, castoreum, ambergris
  • plant fragrances such as nutmeg extract, cardomon extract, ginger extract, cinnamon extract, patchouli
  • fragrance materials include, but are not limited to, chemical substances such as acetophenone, adoxal, aldehyde C-12, aldehyde C-14, aldehyde C-18, allyl caprylate, ambroxan, amyl acetate, dimethylindane derivatives, ⁇ -amylcinnamic aldehyde, anethole, anisaldehyde, benzaldehyde, benzyl acetate, benzyl alcohol and ester derivatives, benzyl propionate, benzyl salicylate, borneol, butyl acetate, camphor, carbitol, cinnamaldehyde, cinnamyl acetate, cinnamyl alcohol, cis-3-hexanol and ester derivatives, cis-3-hexenyl methyl carbonate, citral, citronnellol and ester derivatives, cumin aldehyde,
  • Cyclic Oligosaccharides A second essential element of the compositions of the present invention is that they comprise a cyclic oligosaccharide having one or more unsubstituted alkyl substituents.
  • cyclic oligosaccharide means a cyclic structure comprising six or more saccharide units.
  • Preferred for use herein are cyclic oligosaccharides having six, seven or eight saccharide units and mixtures thereof, more preferably seven saccharide units. It is common in the art to abbreviate six, seven and eight membered cyclic oligosaccharides to ⁇ , ⁇ and ⁇ respectively.
  • compositions of the present invention preferably comprise from about 0.001 % to about 40%, more preferably from about 0.1 % to about 25%, even more preferably from about 1 % to about 20%, especially from about 2% to about 15%, by weight, of cyclic oligosaccharide.
  • the cyclic oligosaccharide of the present invention may comprise any suitable saccharide or mixtures of saccharides.
  • suitable saccharides include, but are not limited to, glucose, fructose, mannose, galactose, maltose and mixtures thereof.
  • preferred for use herein are cyclic oligosaccharides of glucose. Therefore, the preferred cyclic oligosaccharides for use herein are ⁇ -cyclodextrins.
  • the cyclic oligosaccharide for use herein may be substituted by any suitable substituent.
  • suitable substituents include, but are not limited to, alkyl groups, hydroxyalkyl groups, aryl groups, maltosyl groups, allyl groups, benzyl groups, alkanoyl groups and mixtures thereof.
  • the substituent is selected from alkyl groups, hydroxyalkyl groups and mixtures thereof. More preferably, the substituent is selected from alkyl groups and mixtures thereof.
  • Preferred alkyl substituents are selected from C C 8 alkyl groups and mixtures thereof, more preferred alkyl substituents are selected from C C 6 alkyl groups and mixtures thereof, even more preferred alkyl substituents are selected from C C 4 alkyl groups and mixtures thereof.
  • Especially preferred alkyl substituents are ethyl and methyl, more especially methyl.
  • the alkyl substituent may be saturated or unsaturated, straight or branched chain but is preferably saturated and straight chain. As used in this paragraph, the term "mixtures thereof means two or more different alkyl groups are substituted on the same cyclic oligosaccharide.
  • the cyclic oligosaccharides of the present invention are preferably substituted only by unsubstituted alkyl substituents. Therefore, the most preferred cyclic oligosaccharides for use herein are methyl- ⁇ -cyclodextrins. Preferred methyl- ⁇ - cyclodextrins are available from Wacker-Chemie GmbH Hanns-Seidel-Platz 4, Munchen, DE under the tradename Beta W7 M1.8.
  • the cyclic oligosaccharides of the present invention have an average degree of substitution of at least about 1.6.
  • Preferred cyclic oligosaccharides for use herein have an average degree of substitution of less than about 2.8. More preferably the cyclic oligosaccharides for use herein have an average degree of substitution of from about 1.7 to about 2.0.
  • degree of substitution means the average number of substituents per saccharide unit. The average number of substituents can be determined using common Nuclear Magnetic Resonance techniques known in the art.
  • the cyclic oligosaccharides of the present invention are preferably soluble in both water and ethanol.
  • soluble means at least about 0.1 g of solute dissolves in 100ml of solvent, at 25°C and 1 atm of pressure.
  • the cyclic oligosaccharides for use herein have a solubility of at least about 1g/100ml, more preferably at least about 10g/100ml, even more preferably at least about 100g/100ml, at 25°C and 1atm of pressure.
  • the weight ratio of total fragrance to cyclic oligosaccharide in the compositions of the present invention is at least about 1 :1 , more preferably at least about 1.5:1 , even more preferably at least about 2:1.
  • compositions herein can contain a variety of other optional components suitable for rendering such compositions more cosmetically or aesthetically acceptable or to provide them with additional usage benefits.
  • Such conventional optional ingredients are well-known to those skilled in the art. These include any cosmetically acceptable ingredients such as those found in the CTFA International Cosmetic Ingredient Dictionary and Handbook, 7th edition, edited by Wenninger and McEwen, (The Cosmetic, Toiletry, and Fragrance Association, Inc., Washington, D.C., 1997).
  • cosmetically acceptable means a material (e.g., compound or composition) which is suitable for use in contact with skin, hair or other suitable substrate as defined hereinbelow.
  • compositions of the present invention will preferably comprise a cosmetically acceptable carrier.
  • Cosmetically acceptable carrier means one or more compatible solid or liquid fillers, diluents, extenders and the like, which are cosmetically acceptable as defined hereinabove.
  • compatible means that the components of the compositions of this invention are capable of being combined with the primary actives of the present invention, and with each other, in a manner such that there is no interaction which would substantially reduce the efficacy of the composition under ordinary use situations.
  • the type of carrier utilized in the present invention depends on the type of product desired.
  • the compositions useful in the present invention may be a wide variety of product types. These include, but are not limited to, lotions, creams, gels, sticks, sprays, ointments, pastes, mousses and cosmetics (e.g., solid, semi-solid, or liquid make-up, including foundations).
  • product types may comprise several types of carriers including, but not limited to, solutions, aerosols, emulsions (including oil-in-water or water-in-oil), gels, solids, and liposomes.
  • solutions including aerosols, emulsions (including oil-in-water or water-in-oil), gels, solids, and liposomes.
  • compositions of the present invention preferably comprise a volatile solvent or mixture of volatile solvents.
  • the solvents for use herein are preferably organic volatile solvents. If present, the volatile solvent or mixture of solvents will generally be at a level of about 5% or greater, preferably about 10% or greater, more preferably about 20% or greater, even more preferably about 50% or greater, by weight of total composition.
  • volatile refers to substances with a significant amount of vapour pressure under ambient conditions, as is understood by those in the art.
  • the volatile solvents for use herein will preferably have a vapour pressure of about 2kPa or more, more preferably about 6kPa or more, at 25°C.
  • the volatile solvents for use herein will preferably have a boiling point under one atmosphere (atm) of less than about 150°C, more preferably less than about 100°C, even more preferably less than about 90°C, even more preferably still less than about 80°C.
  • the volatile solvents for use herein will be relatively odourless and safe for use on human skin.
  • Suitable volatile solvents include, but are not limited to, C,-C 4 alcohols, volatile silicones and mixtures thereof.
  • Preferred volatile solvents are C C 4 alcohols and mixtures thereof. More preferred for use herein is ethanol.
  • Nonvolatile solvents While the compositions of the present invention preferably comprise a volatile solvent they may also comprise "nonvolatile" solvents. Suitable non-volatile solvents include, but are not limited to, benzyl benzoate, diethyl phtalate, isopropyl myristate, and mixtures thereof.
  • Particularly preferred for use herein for providing increased longevity and strength of odour of fragrance is a low molecular weight polyol molecular wedge having from about 2 to about 12 carbon atoms, preferably from about 2 to about 6 carbon atoms and at least one -OH functional group, preferably at least 2 -OH functional groups.
  • These polyols can further contain ether groups within the carbon chain. Suitable examples include ethylene glycol, propylene glycol, dipropylene glycol, 1 ,4-butanediol, 1 ,6-hexanediol and mixtures thereof.
  • these polyols are present at a level of from about 0.01 % to about 20%, preferably from about 0.1 % to about 10%, and especially from about 0.5% to about 5% by weight of composition. It is preferred that the molar ratio of molecular wedge material to oligosaccharide is from 10:1 to 1 :10, preferably 1 :1 or greater, especially 1 :1.
  • the above mentioned molecular wedge molecules form tertiary inclusion complexes with the complexed perfume material and the cyclic oligosaccharide.
  • These small dipolar molcules can fit into the cavity of the cyclic oligosaccharide and anchor via their OH groups onto the outside rim of the cyclic oligosaccharide through hydrogen bonding. This enables the inclusion of all or parts of the fragrance material into the cavity of the cyclic oligosaccharide such that the stability of the formed tertiary complex is increased versus the complex formed by the fragrance material and cyclic oligosaccharide alone.
  • compositions of the present invention may also comprise water. If present, the water will preferably comprise from about 0.1 % to about 40%, more preferably from about 1 % to about 30%, even more preferably about 5% to about 20%, by weight, of total composition.
  • alcohol denaturants such as denatonium benzoate
  • UV stabilisers such as benzophenone-2
  • antioxidants such as tocopheryl acetate
  • preservatives such as phenoxyethanol, benzyl alcohol, methyl paraben, propyl paraben
  • dyes pH adjusting agents such as lactic acid, citric acid, sodium citrate, succinic acid, phosphoric acid, sodium hydroxide, sodium carbonate
  • deodorants and antimicrobials such as farnesol and zinc phenolsulphonate
  • humectants such as glycerine
  • oils skin conditioning agents such as allantoin
  • cooling agents such as trimethyl isopropyl butanamide and menthol
  • hair conditioning ingredients such as panthenol, panthetine, pantotheine, panthenyl ethyl ether, and combinations thereof
  • silicones such as hexyl
  • compositions of the present invention can be used to provide a long-lasting fragrance to a suitable substrate.
  • suitable substrate means any surface to which the present composition may be applied without an unduly adverse effect.
  • suitable substrates include, but are not limited to, skin, hair and fabrics.
  • the present compositions are applied to skin or hair, especially skin.
  • the cosmetic compositions of the present invention may be used in a conventional manner for fragrancing a suitable substrate.
  • An effective amount of the composition typically from about 1 ⁇ l to about 1000 ⁇ l, preferably from about 10 ⁇ l to about 250 ⁇ l, more preferably from about 25 ⁇ l to about 100 ⁇ l, is applied to the substrate.
  • the composition may be applied by hand but is preferably applied utilising a vaporiser. Preferably, the composition is then left to dry.
  • the preferred method of treating the substrate comprises:
  • compositions of the present invention may take any form suitable for cosmetic use. These include, but are not limited to, vapour sprays, aerosols, emulsions, solid sticks, lotions and liquids. Preferably the compositions of the present invention take the form of a vapour spray.
  • Beta W7 M1.8 available from Wacker-C emie GmbH, Hanns-Sei el-Platz 4, Munchen, DE
  • the cyclic oligosaccharide was dissolved in the ethanol at room temperature, with stirring. Then the fragrance and water were added with stirring.
  • Beta W7 M1.8 available from Wacker-Chemie GmbH, Hanns-Seidel-Platz 4, Munchen, DE
  • the cyclic oligosaccharide was dissolved in the ethanol at room temperature, with stirring. Then the fragrance was added with stirring.
  • Beta W7 M1.8 available from Wacker-Chemie GmbH, Hanns-Seidel-Platz 4, Munchen, DE
  • a propellant such as propane butane (CAP 40®) can be added to Examples VII-IX according to standard industry practice.
  • Beta W7 M1.8 available from Wacker-Chemie GmbH, Hanns-Seidel-Platz 4, Munchen, DE
  • the cyclic oligosaccharide was dissolved in the ethanol at room temperature, with stirring. Then the fragrance, dipropylene glycol/ethylene glycol and water were added with stirring.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

Cette invention concerne des compositions cosmétiques renfermant: (a) plus de 0,2 % en poids d'un parfum; et (b) un oligosaccharide cyclique ayant un taux de substitution moyen d'au moins 1,6 environ. Les compositions selon l'invention dégagent durablement leur parfum, avec dégagement intense du parfum à l'application.
EP00926513A 1999-05-07 2000-05-05 Composition cosmetique renfermant un oligosaccharide cyclique et un parfum Ceased EP1176942A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US1999/009907 WO2000067716A1 (fr) 1999-05-07 1999-05-07 Compositions cosmetiques renfermant des oligosaccharides cycliques et un parfum
WOPCT/US99/09907 1999-05-07
PCT/US2000/012415 WO2000067718A1 (fr) 1999-05-07 2000-05-05 Composition cosmetique renfermant un oligosaccharide cyclique et un parfum

Publications (1)

Publication Number Publication Date
EP1176942A1 true EP1176942A1 (fr) 2002-02-06

Family

ID=22272696

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00926513A Ceased EP1176942A1 (fr) 1999-05-07 2000-05-05 Composition cosmetique renfermant un oligosaccharide cyclique et un parfum

Country Status (3)

Country Link
EP (1) EP1176942A1 (fr)
AU (2) AU3885199A (fr)
WO (2) WO2000067716A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
WO2012138696A2 (fr) 2011-04-07 2012-10-11 The Procter & Gamble Company Compositions de shampooing à dépôt accru de microcapsules de polyacrylate
CN103458871B (zh) 2011-04-07 2015-05-13 宝洁公司 具有增强的聚丙烯酸酯微胶囊的沉积的调理剂组合物
WO2012138710A2 (fr) 2011-04-07 2012-10-11 The Procter & Gamble Company Compositions d'hygiène personnelle à dépôt accru de microcapsules de polyacrylate
US20120322709A1 (en) 2011-05-26 2012-12-20 Jianjun Justin Li Compositions comprising an efficient perfume bloom
US11279774B2 (en) 2019-01-03 2022-03-22 Underdog Pharmaceuticals, Inc. Cyclodextrin dimers, compositions thereof, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH082773B2 (ja) * 1987-02-06 1996-01-17 花王株式会社 ロ−シヨン組成物
DE29522186U1 (de) * 1994-08-12 2000-06-15 The Procter & Gamble Company, Cincinnati, Ohio Zusammensetzung zur Verringerung der Wahrnehmung eines unangenehmen Geruchs von unbelebten Oberflächen
CN1072967C (zh) * 1994-08-12 2001-10-17 普罗格特-甘布尔公司 未配位环糊精溶液、制成品及其使用方法
JPH08176587A (ja) * 1994-12-27 1996-07-09 Shiseido Co Ltd 香料組成物
US5861145A (en) * 1997-06-09 1999-01-19 The Procter & Gamble Company Method of reducing body odor using perfumed, odor absorbing, two phase compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 12, no. 472 (C - 551)<3319> 9 December 1998 (1998-12-09) *
See also references of WO0067718A1 *

Also Published As

Publication number Publication date
AU3885199A (en) 2000-11-21
WO2000067718A1 (fr) 2000-11-16
AU4503200A (en) 2000-11-21
WO2000067716A1 (fr) 2000-11-16

Similar Documents

Publication Publication Date Title
EP1176945B1 (fr) Compositions cosmetiques
US6893647B1 (en) Cosmetic compositions
US7919452B2 (en) Hydro-alcoholic cosmetic compositions with a delayed release
US7208463B2 (en) Fragrance compositions
US7208464B2 (en) Fragrance compositions
EP1176944B1 (fr) Compositions cosmetiques
US7407650B2 (en) Fragrance compositions
US20030119713A1 (en) Fragrance compositions
US7041337B2 (en) Methods of fragrancing a surface
EP1289484B2 (fr) Compositions de parfum
EP1289485B1 (fr) Compositions de fragrance
EP1176942A1 (fr) Composition cosmetique renfermant un oligosaccharide cyclique et un parfum
EP1330234B1 (fr) Compositions de parfum
EP1331920B1 (fr) Procedes permettant de parfumer une surface
EP1280509B1 (fr) Compositions contenant des solvants volatils
EP1289483B1 (fr) Compositions de fragrance
EP1176943A1 (fr) Compositions cosmetiques

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011123

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20040119

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20090108